CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported EPS (Basic) of -$1.28 for Q1 2026, up 19.12% on a YoY basis from -$1.07 in Q1 2025, and up 29.06% sequentially from -$1.8 in Q4 2025.
CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 12 years of EPS (Basic) data on file, last reported at -$1.28 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 19.12% year-over-year to -$1.28; the trailing twelve-month figure through Mar 2026 stood at -$6.25 (down 3044.61% YoY), and the FY2025 full-year result was -$6.82, down 1628.11% from the prior year.
- EPS (Basic) climbed to -$1.28 in Q1 2026, from -$1.8 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.35 in Q4 2024 to a low of -$2.4 in Q2 2022.
- A 5-year average of -$1.07 and a median of -$1.42 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 285.11% in 2024 and sank 141.52% in 2025, its largest moves.
- Tracing CRSP's EPS (Basic) over 5 years: stood at -$1.42 in 2022, then surged by 179.34% to $1.13 in 2023, then jumped by 285.11% to $4.35 in 2024, then slumped by 141.52% to -$1.8 in 2025, then gained by 29.06% to -$1.28 in 2026.
- Business Quant data shows CRSP's EPS (Basic) at -$1.28 in Q1 2026, -$1.8 in Q4 2025, and -$1.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | CRISPR Therapeutics AG | 4.47 Bn | 2.03 Bn | - | -1.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.28 |
| Dec 31, 2025 | -1.80 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -2.40 |
| Mar 31, 2025 | -1.58 |
| Dec 31, 2024 | 4.35 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -1.43 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -1.42 |
| Sep 30, 2022 | -2.24 |
| Jun 30, 2022 | -2.40 |
| Mar 31, 2022 | -2.32 |
| Dec 31, 2021 | -1.86 |
| Sep 30, 2021 | -1.67 |
| Jun 30, 2021 | 10.01 |